BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6167030)

  • 1. Effect of antithymocyte globulin on histocompatibility antigen recognition in man.
    Harada M; Gale RP
    Transplantation; 1981 Feb; 31(2):101-5. PubMed ID: 6167030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of antithymocyte globulin for human bone marrow transplantation. Antihematopoietic and immunosuppressive activity.
    Harada M; Gale RP
    Transplantation; 1982 Jun; 33(6):625-30. PubMed ID: 7048664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immune responses to hapten-conjugated cells. II. The roles of autologous and allogeneic histocompatibility determinants in proliferative responses in vitro.
    Seldin MF; Rich RR; Dupont B
    J Immunol; 1979 May; 122(5):1828-33. PubMed ID: 87444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self recognition in allogeneic radiation bone marrow chimeras. A radiation-resistant host element dictates the self specificity and immune response gene phenotype of T-helper cells.
    Singer A; Hathcock KS; Hodes RJ
    J Exp Med; 1981 May; 153(5):1286-301. PubMed ID: 6166716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of antithymocyte globulin on anti-human leukocyte antigen antibody detection assays.
    Gloor JM; Moore SB; Schneider BA; Degoey SR; Stegall MD
    Transplantation; 2007 Jul; 84(2):258-64. PubMed ID: 17667819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo - in vitro correlates of antithymocyte globulin (ATG) immunosuppression in the human.
    Thomas F; Berry R; Mendez-Picon G; Thomas J; Lower RR; Lee HM
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():56-61. PubMed ID: 386321
    [No Abstract]   [Full Text] [Related]  

  • 7. Modulation of alloimmune response by commensal gut microbiota and potential new avenues to influence the outcome of allogeneic transplantation by modification of the 'gut culture'.
    Kanangat S
    Int J Immunogenet; 2017 Feb; 44(1):1-6. PubMed ID: 28044415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major histocompatibility complex-restricted self-recognition in responses to trinitrophenyl-ficoll. Adaptive differentiation and self-recognition by B cells.
    Singer A; Hodes RJ
    J Exp Med; 1982 Nov; 156(5):1415-34. PubMed ID: 6982306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen recognition by MHC-incompatible cells of a human mismatched chimera.
    Roncarolo MG; Yssel H; Touraine JL; Bacchetta R; Gebuhrer L; De Vries JE; Spits H
    J Exp Med; 1988 Dec; 168(6):2139-52. PubMed ID: 2462006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens.
    Engleman EG; Benike CJ; Grumet FC; Evans RL
    J Immunol; 1981 Nov; 127(5):2124-9. PubMed ID: 6457863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human suppressor cell induction in vitro: preferential activation by class I MHC antigen.
    Goeken NE
    J Immunol; 1984 May; 132(5):2291-9. PubMed ID: 6232315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental transplantation and histocompatibility systems in the canine species.
    Rapaport FT; Bachvaroff RJ
    Adv Vet Sci Comp Med; 1978; 22():195-219. PubMed ID: 153705
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
    Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
    Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of antithymocyte serum in clinical and experimental marrow transplantation.
    Storb R; Weiden PL; Thomas ED
    Postgrad Med J; 1976; 52(5 Suppl):96-103. PubMed ID: 11456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DR human histocompatibility leukocyte antigens-restricted lymphocyte-monocyte interactions in the release from monocytes of acidic isoferritins that suppress hematopoietic progenitor cells.
    Broxmeyer HE; Juliano L; Lu L; Platzer E; Dupont B
    J Clin Invest; 1984 Apr; 73(4):939-53. PubMed ID: 6231314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved allograft survival of strong immune responder-high risk recipients with adjuvant antithymocyte globulin therapy.
    Kerman RH; Floyd M; Van Buren CT; Kahan BD
    Transplantation; 1980 Dec; 30(6):450-4. PubMed ID: 7008294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Antithymocyte Globulin Source on Outcomes of HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia.
    Chen X; Wei J; Huang Y; He Y; Yang D; Zhang R; Jiang E; Ma Q; Zhai W; Yao J; Zhang G; Feng S; Han M
    Biol Blood Marrow Transplant; 2018 Jan; 24(1):86-90. PubMed ID: 29032265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease.
    Goulmy E; Gratama JW; Blokland E; Zwaan FE; van Rood JJ
    Nature; 1983 Mar; 302(5904):159-61. PubMed ID: 6186923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways.
    Singer A; Kruisbeek AM; Andrysiak PM
    J Immunol; 1984 May; 132(5):2199-209. PubMed ID: 6201534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic bone marrow transplantation with related donors other than HLA MLC-matched siblings, and the use of antithymocyte globulin, prednisone, and methotrexate for prophylaxis of graft-versus-host disease.
    Filipovich AH; Ramsay NK; Arthur DC; McGlave P; Kim T; Kersey JH
    Transplantation; 1985 Mar; 39(3):282-5. PubMed ID: 3156437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.